- Home
- AUPH vs SCSC Comparison
AUPH vs SCSC Comparison
Compare AUPH & SCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | SCSC |
|---|---|---|
| Founded | 1993 | 1992 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 769.9M |
| IPO Year | 2014 | 1997 |
Fundamental Metrics
Financial Performance| Metric | AUPH | SCSC |
|---|---|---|
| Price | $14.28 | $36.13 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $17.25 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 1.1M | 163.2K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | ★ 2.07 | 1.63 |
| Revenue | $283,055,000.00 | ★ $3,846,260,000.00 |
| Revenue This Year | $16.53 | $2.60 |
| Revenue Next Year | $16.24 | $4.01 |
| P/E Ratio | ★ $7.06 | $22.57 |
| Revenue Growth | ★ 20.38 | 7.79 |
| 52 Week Low | $6.83 | $28.76 |
| 52 Week High | $16.54 | $46.25 |
Technical Indicators
Market Signals| Indicator | AUPH | SCSC |
|---|---|---|
| Relative Strength Index (RSI) | 48.71 | 46.90 |
| Support Level | $13.52 | $35.57 |
| Resistance Level | $15.23 | $42.84 |
| Average True Range (ATR) | 0.46 | 1.10 |
| MACD | 0.02 | 0.22 |
| Stochastic Oscillator | 33.82 | 65.14 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About SCSC ScanSource Inc.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Intelisys & Advisory Segment. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States and Canada, and also has its presence in Brazil, and other countries.